[EN] 4'-AZIDO, 3'-FLUORO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION [FR] DÉRIVÉS NUCLÉOSIDIQUES 4'-AZIDO, 3'-FLUORO SUBSTITUÉS EN TANT QU'INHIBITEURS DE LA RÉPLICATION DE L'ARN DU VHC
[EN] 4'-AZIDO, 3'-FLUORO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION [FR] DÉRIVÉS NUCLÉOSIDIQUES 4'-AZIDO, 3'-FLUORO SUBSTITUÉS EN TANT QU'INHIBITEURS DE LA RÉPLICATION DE L'ARN DU VHC
4'-AZIDO, 3'-FLUORO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
申请人:Hoffmann-La Roche Inc.
公开号:US20140369959A1
公开(公告)日:2014-12-18
The present invention relates to the use of nucleoside derivatives of formula (I) wherein the symbols are as the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.
4'-AZIDO-3'-FLUORO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
申请人:Riboscience LLC
公开号:EP2794628B1
公开(公告)日:2017-03-29
US20140341848A1
申请人:——
公开号:US20140341848A1
公开(公告)日:2014-11-20
4'-AZIDO, 3'-DEOXY-3'-FLUORO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
申请人:Riboscience LLC
公开号:US20160220596A1
公开(公告)日:2016-08-04
The present disclosure relates to the compound of Formula I:
Also disclosed are pharmaceutical compositions comprising the compound of Formula I, methods of using the compound of Formula I and/or compositions comprising the compound of Formula I for the treatment of HCV.